What You Should Know:
– Serve You Rx announced today the inclusion of two newly approved biosimilars to Stelara® (ustekinumab) – Otulfi™ (ustekinumab-aauz) and Yesintek™ (ustekinumab-face) – to its Biosimilar Advantage Formulary. This move is set to deliver substantial savings for self-funded employers and health-plan sponsors while maintaining therapeutic benefits for patients with conditions like Crohn’s disease, ulcerative colitis, plaque psoriasis, and psoriatic arthritis.
– Serve You Rx, a full-service pharmacy benefit manager (PBM), is expanding its cost-saving solutions by incorporating Otulfi™ and Yesintek™, biosimilars to the widely used specialty drug Stelara®.
Significant Cost Reduction Opportunities
“The numbers tell the story here,” stated Justin Jasniewski, CEO of Serve You Rx. “With savings of up to 96% compared to as much as $152,000 annually for Stelara, these biosimilars represent a significant opportunity for our clients to manage healthcare costs while maintaining quality care for their members.”
This initiative is a collaborative effort with Mark Cuban Cost Plus Drugs and Waltz Health, aimed at improving access to high-cost specialty medications through transparent pricing and simplified distribution channels.
Collaborative Approach to Enhance Access and Affordability
“Making biosimilars like Otulfi available through Cost Plus Drugs is another step toward breaking down barriers to access,” said Dr. Alex Oshmyansky, CEO of Mark Cuban Cost Plus Drug Company. “By working with Serve You Rx, we’re helping more patients and health plans avoid the inflated costs that have defined the specialty drug market for too long.”
Details of the distribution include:
- Otulfi™: To be dispensed exclusively through Mark Cuban Cost Plus Drugs via the Waltz Health specialty pharmacy network. Members are projected to save more than 96% annually compared to Stelara®.
- Yesintek™: Will be available through Serve You Rx’s specialty pharmacy network, powered by Waltz Health. It is expected to deliver over 90% annualized savings for plan sponsors while treating the same conditions as Stelara®.
Both medications will be supported by robust copay assistance programs to ensure patient access without imposing financial barriers.
Waltz Health offers a comprehensive solution that includes a specialty pharmacy network competing on price and service, a guided patient experience, and a flexible service model designed to balance cost and patient outcomes.
